Research Topics
Species | A H DanserSummaryAffiliation: Erasmus University Country: The Netherlands Publications
| Collaborators
|
Detail Information
Publications
Prorenin, renin, angiotensinogen, and angiotensin-converting enzyme in normal and failing human hearts. Evidence for renin bindingA H Danser
Department of Pharmacology, Cardiovasculair Onderzoeksinstituut Erasmus Universiteit Rotterdam, Netherlands
Circulation 96:220-6. 1997..A local renin-angiotensin system in the heart is often invoked to explain the beneficial effects of ACE inhibitors in heart failure. The heart, however, produces little or no renin under normal conditions...
Prorenin uptake in the heart: a prerequisite for local angiotensin generation?A H Jan Danser
Department of Pharmacology, Erasmus MC, Rotterdam, The Netherlands
J Mol Cell Cardiol 34:1463-72. 2002..e., immediate binding of angiotensin II to its receptors with minimal loss into the extracellular space...
Local renin-angiotensin systems: the unanswered questionsA H Jan Danser
Department of Pharmacology, Room EE1418b, Erasmus Medical Centre, Dr Molewaterplein 50, 3015 GE Rotterdam, The Netherlands
Int J Biochem Cell Biol 35:759-68. 2003..with the local generation or effects of angiotensin II), and (5) to what degree do differences in tissue angiotensin generation underlie the association between cardiovascular diseases and renin-angiotensin system gene polymorphisms?..
Renin-angiotensin system gene polymorphisms: potential mechanisms for their association with cardiovascular diseasesA H Danser
Room EE1418b Department of Pharmacology, Erasmus University Rotterdam, Dr Molewaterplein 50, 3015 GE, Rotterdam, Netherlands
Eur J Pharmacol 410:303-316. 2000....
L-NAME-resistant bradykinin-induced relaxation in porcine coronary arteries is NO-dependent: effect of ACE inhibitionA H Danser
Department of Pharmacology, Erasmus University Rotterdam, Rotterdam, The Netherlands
Br J Pharmacol 131:195-202. 2000..ACE inhibitors potentiate BK independent of their effect on BK metabolism...
Angiotensin I to angiotensin II conversion in the human forearm and leg. Effect of the angiotensin converting enzyme gene insertion/deletion polymorphismA H Danser
Cardiovasculair Onderzoeksinstituut Erasmus Universiteit Rotterdam, The Netherlands
J Hypertens 17:1867-72. 1999..Here we quantify ACE genotype-related Ang I to Ang II conversion in the human forearm and leg using non-pressor 125I-Ang I infusions...
Is there a local renin-angiotensin system in the heart?A H Danser
Department of Pharmacology, Erasmus University Rotterdam, The Netherlands
Cardiovasc Res 44:252-65. 1999..In addition, the role of alternative angiotensin-generating enzymes (cathepsin, chymase) and the possibility of (pro)renin uptake from the circulation is evaluated...
Angiotensin I-to-II conversion in the human renal vascular bedA H Danser
Department of Pharmacology, Erasmus University Rotterdam, The Netherlands
J Hypertens 16:2051-6. 1998..To overcome this problem, we now infused 125I-angiotensin I directly into the renal artery...
Angiotensinogen (M235T) and angiotensin-converting enzyme (I/D) polymorphisms in association with plasma renin and prorenin levelsA H Danser
Cardiovascular Research Institute COEUR, Department of Pharmacology, Erasmus University Rotterdam, The Netherlands
J Hypertens 16:1879-83. 1998....
Bradykinin-induced release of nitric oxide by the isolated perfused rat heart: importance of preformed pools of nitric oxide-containing factorsA H Danser
Department of Pharmacology, Cardiovasculair Onderzoeksinstituut Erasmus Universiteit Rotterdam, The Netherlands
J Hypertens 16:239-44. 1998..To study whether the vasorelaxant effect of bradykinin in the coronary vascular bed depends on the release of NO from preformed pools and/or de-novo synthesis of NO resulting from bradykinin-induced stimulation of NO synthase...
Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humansA H Danser
Department of Pharmacology, Cardiovasculaire Onderzoeksinstituut Erasmus Universiteit Rotterdam, The Netherlands
J Hypertens 16:853-62. 1998..Plasma renin concentrations are an important factor in cardiovascular risk profiling...
AT(2) receptor-mediated vasodilation in the heart: effect of myocardial infarctionM P Schuijt
Department of Pharmacology, Erasmus University Rotterdam, The Netherlands
Am J Physiol Heart Circ Physiol 281:H2590-6. 2001..RVC, at baseline or with ANG II, was not affected by PD123319 in infarcted and sham animals. In conclusion, coronary but not renal AT(2) receptor stimulation results in vasodilation, and this effect is enhanced in infarcted rats...
Cardiomyocytes bind and activate native human prorenin : role of soluble mannose 6-phosphate receptorsJ J Saris
Cardiovascular Research Institute COEUR, Department of Pharmacology, Internal Medicine, Erasmus University Rotterdam, The Netherlands
Hypertension 37:710-5. 2001....
Angiotensin converting enzyme is the main contributor to angiotensin I-II conversion in the interstitium of the isolated perfused rat heartL M de Lannoy
Department of Pharmacology, Erasmus University Rotterdam, The Netherlands
J Hypertens 19:959-65. 2001..CONCLUSIONS: In the intact rat heart, ACE is the main contributor to angiotensin I to angiotensin II conversion, both in the coronary vascular bed and the interstitium. Cardiac ACE is not limited to the coronary vascular endothelium...
Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C- and N-domain blockadeB Tom
Department of Pharmacology, Erasmus University Rotterdam, The Netherlands
Hypertension 38:95-9. 2001..The inhibitory effects of Ang-(1-7) are limited to the ACE C-domain, raising the possibility that Ang-(1-7) synergistically increases the blood pressure-lowering effects of N-domain-specific ACE inhibitors...
Negative inotropic effect of bradykinin in porcine isolated atrial trabeculae: role of nitric oxideB Tom
Department of Pharmacology, Erasmus University Rotterdam, The Netherlands
J Hypertens 19:1289-93. 2001..The inconsistent results obtained with L-NAME suggest that it depends on NO synthesized de novo and/or NO from storage sites...
Prorenin accumulation and activation in human endothelial cells: importance of mannose 6-phosphate receptorsM M van den Eijnden
Cardiovascular Research Institute COEUR, Department of Pharmacology, Erasmus University Rotterdam, Rotterdam, The Netherlands
Arterioscler Thromb Vasc Biol 21:911-6. 2001..Most likely, therefore, in the absence of angiotensinogen synthesis or endocytosis, M6P receptor-mediated prorenin internalization by endothelial cells represents prorenin clearance...
Intrarenal angiotensin II: interstitial and cellular levels and site of productionJ P van Kats
Cardiovascular Research Institute Erasmus University Rotterdam (COEUR, Department of Internal Medicine, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands
Kidney Int 60:2311-7. 2001..We propose the existence of a low-Ang II vascular system-related interstitial compartment that is separate from tubular fluid, where, according to micropuncture studies, Ang II levels might be high...
Angiotensin II type 2 receptors and cardiac hypertrophy in women with hypertrophic cardiomyopathyJ Deinum
Cardiovascular Research Institute of the Erasmus University Rotterdam COEUR, Department of Internal Medicine, Erasmus University Rotterdam, Rotterdam, The Netherlands
Hypertension 38:1278-81. 2001..In conclusion, AT(2)-Rs modulate cardiac hypertrophy in women with HCM, independently of the circulating renin-angiotensin system. These data support the contention that AT(2)-Rs mediate antitrophic effects in humans...
Superoxide does not mediate the acute vasoconstrictor effects of angiotensin II: a study in human and porcine arteriesMartin P Schuijt
Department of Pharmacology, Erasmus MC, Rotterdam, The Netherlands
J Hypertens 21:2335-44. 2003..CONCLUSIONS: Acute vasoconstriction by Ang II is not mediated via superoxide generated through NAD(P)H oxidase and/or XO activation. Such activation, if occurring, rather results in the generation of the vasodilator H2O2...
The (pro)renin receptor: therapeutic consequencesGenevieve Nguyen
Expert Opin Investig Drugs 15:1131-5. 2006..Ultimately, this could lead to the development of (pro)renin receptor blockers (i.e., drugs that not only prevent tissue angiotensin generation but also inhibit renin- or prorenin-induced effects)...
Prorenin: back into the arenaA H Jan Danser
Hypertension 47:824-6. 2006
Pharmacogenetics of ACE inhibition in stable coronary artery disease: steps towards tailored drug therapyJasper J Brugts
Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands
Curr Opin Cardiol 23:296-301. 2008..This review discusses several approaches to guide angiotensin-converting enzyme-inhibition therapy to more specific groups of patients that are most likely to benefit...
Renin, prorenin and the putative (pro)renin receptorA H Jan Danser
Department of Pharmacology, Erasums MC, Rotterdam, The Netherlands
J Renin Angiotensin Aldosterone Syst 6:163-5. 2005
ACE phenotyping as a first step toward personalized medicine for ACE inhibitors. Why does ACE genotyping not predict the therapeutic efficacy of ACE inhibition?A H Jan Danser
Department of Pharmacology, Erasmus MC, University Medical Center Rotterdam, P O Box 1738, 3000 DR Rotterdam, The Netherlands
Pharmacol Ther 113:607-18. 2007....
Letter by Krop et al regarding article, "Role of p90 ribosomal S6 kinase-mediated prorenin-converting enzyme in ischemic and diabetic myocardium"Manne Krop
Circulation 114:e556; author reply e557. 2006
Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or beta-blockersHedi Schelleman
Department of Epidemiology and Biostatistics, Erasmus MC, Rotterdam, The Netherlands
Eur J Hum Genet 15:478-84. 2007..ACE-inhibitor users with at least one copy of the 235T-allele of the AGT gene might have an increased risk of MI and stroke...
Novel drugs targeting hypertension: renin inhibitorsA H Jan Danser
Department of Pharmacology, Erasmus MC, Rotterdam, The Netherlands
J Cardiovasc Pharmacol 50:105-11. 2007..The review ends with a brief overview of the available (pre)clinical aliskiren data and a description of its safety profile...
Prorenin is the endogenous agonist of the (pro)renin receptor. Binding kinetics of renin and prorenin in rat vascular smooth muscle cells overexpressing the human (pro)renin receptorWendy W Batenburg
Erasmus MC, Rotterdam, The Netherlands
J Hypertens 25:2441-53. 2007..Here, we evaluated the kinetics of renin/prorenin binding to the recently discovered human (pro)renin receptor (h(P)RR), and the idea that such binding underlies tissue angiotensin generation...
Renin academy in focusA H Jan Danser
Department of Internal Medicine, room E1418b, Erasmus MC, s Gravendijkwal 230, Rotterdam, The Netherlands
J Renin Angiotensin Aldosterone Syst 8:212. 2007
Prorenin anno 2008A H Jan Danser
Division of Vascular Pharmacology and Metabolism, Department of Internal Medicine, Erasmus MC, Dr Molewaterplein 50, Rotterdam, The Netherlands
J Mol Med (Berl) 86:655-8. 2008..The review ends with the concept that prorenin rather than renin determines tissue angiotensin generation...
Aliskiren-binding increases the half life of renin and prorenin in rat aortic vascular smooth muscle cellsWendy W Batenburg
Erasmus MC, 3015 GE Rotterdam, The Netherlands
Arterioscler Thromb Vasc Biol 28:1151-7. 2008..We also investigated whether aliskiren affects (pro)renin binding to its receptors, using rat aortic vascular smooth muscle cells (VSMCs) overexpressing the h(P)RR...
Circulating versus tissue renin-angiotensin system: on the origin of (pro)reninManne Krop
Division of Vascular Pharmacology and Metabolism, Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands
Curr Hypertens Rep 10:112-8. 2008..This review provides an update on the sources of (pro)renin in the body, lists the known stimulants and inhibitors of its production, and discusses the concept that prorenin rather than renin determines tissue angiotensin generation...
Renin, prorenin and the putative (pro)renin receptorA H Jan Danser
Department of Pharmacology, Erasmus MC, Rotterdam, The Netherlands
Hypertension 46:1069-76. 2005
Transendothelial transport of renin-angiotensin system componentsMark M E D van den Eijnden
Department of Pharmacology, Cardiovascular Research Institute COEUR, Erasmus Medical Center, Rotterdam, The Netherlands
J Hypertens 20:2029-37. 2002..CONCLUSIONS: Circulating (pro)renin, angiotensinogen, ANG I and ANG II enter the interstitium via diffusion, and interstitial ANG II generation is mediated, at least in part, by basolaterally located endothelial ACE...
The role of locally expressed angiotensin converting enzyme in cardiac remodeling after myocardial infarction in miceWendy M Aartsen
Department of Pharmacology, Cardiovascular Research Institute Maastricht, Universiteit Maastricht, P O Box 616, 6200 MD, Maastricht, The Netherlands
Cardiovasc Res 56:205-13. 2002..In the present study, mice lacking tissue-bound angiotensin converting enzyme (t-ACE -/-) were used to investigate the importance of t-ACE during cardiac remodeling after myocardial infarction...
Prorenin-induced myocyte proliferation: no role for intracellular angiotensin IIJasper J Saris
Cardiovascular Research Institute COEUR, Department of Pharmacology, Erasmus University Medical Center Rotterdam, The Netherlands
Hypertension 39:573-7. 2002..Taken together, our results do not support the concept of Ang II generation in cardiomyocytes following intracellular prorenin activation...
A twofold genetic increase of ACE expression has no effect on the development of spontaneous hypertensionIbrahim Nassar
Institute of Clinical Pharmacology and Toxicology, Charité Centrum für Thearapieforschung, Charite Universitatsmedizin Berlin, Berlin, Germany
Am J Hypertens 21:200-5. 2008..e., the Ace allele of the normotensive Wistar-Kyoto (WKY) rat, in the hypertensive background of stroke-prone spontaneously hypertensive (SHRSP) rats...
Selective angiotensin-converting enzyme C-domain inhibition is sufficient to prevent angiotensin I-induced vasoconstrictionJoep H M van Esch
Department of Pharmacology, Erasmus MC, Rotterdam, The Netherlands
Hypertension 45:120-5. 2005....
Endothelin-1 and blood pressure in womenA H Jan Danser
J Hypertens 22:675-6. 2004
Adrenal angiotensin: origin and site of generationJorge P van Kats
Department of Pharmacology, Erasmus Medical Center, Rotterdam, The Netherlands
Am J Hypertens 18:1104-10. 2005..Our data do not support angiotensin generation by truncated prorenin...
The renin rise with aliskiren: it's simply stoichiometryA H Jan Danser
Hypertension 51:e27-8; author reply e29. 2008
No net effect of angiotensin II on blood pressure?Martin P Schuijt
Hypertension 39:E27-8. 2002
Vasoconstriction is determined by interstitial rather than circulating angiotensin IIMartin P Schuijt
Department of Pharmacology, Erasmus University Medical Centre Rotterdam, Rotterdam, The Netherlands
Br J Pharmacol 135:275-83. 2002..5. Interstitial, rather than circulating Ang II determines vasoconstriction. Arterial Ang I, resulting in high interstitial Ang II levels via its local conversion by ACE, may be of greater physiological importance than arterial Ang II...
Cardiovascular phenotype of mice lacking all three subtypes of angiotensin II receptorsFlorian Gembardt
Department of Cardiology, Charite Berlin, Campus Benjamin Franklin, Berlin, Germany
FASEB J 22:3068-77. 2008....
Cardiac angiotensin II: an intracrine hormone?Martin P Schuijt
Department of Pharmacology, Erasmus Medical Centre, Rotterdam, The Netherlands
Am J Hypertens 15:1109-16. 2002..Intracellular angiotensin II generation is unlikely to occur, in particular because angiotensinogen is not available in the cytosol...
The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failureStefan Klotz
Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York, USA
J Am Coll Cardiol 49:1166-74. 2007..We hypothesized that angiotensin-converting enzyme inhibition (ACE-I) during left ventricular assist device (LVAD) support in patients with end-stage heart failure prevents potentially deleterious effects on the extracellular matrix...
Cardiac aldosterone in subjects with hypertrophic cardiomyopathyWenxia Chai
Department of Pharmacology, Erasmus MC, Dr Molewaterplein 50, 3015 GE Rotterdam, The Netherlands
J Renin Angiotensin Aldosterone Syst 7:225-30. 2006..This finding raises the need for studies determining the benefit of aldosterone blockade in HCM...
Nongenomic effects of aldosterone in the human heart: interaction with angiotensin IIWenxia Chai
Department of Pharmacology, Erasmus MC, 3015 GE Rotterdam, The Netherlands
Hypertension 46:701-6. 2005..These effects are specific and involve PKC and ERK 1/2, respectively. Furthermore, they occur in a nongenomic manner, and require pathological aldosterone concentrations...
Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffnessStefan Klotz
Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, USA
Circulation 112:364-74. 2005..Lack of significant effects on the RV suggest that hemodynamic unloading of the LV (not provided to the RV) might be the primary factor that regulates these extracellular matrix changes...
Cardioprotective effects of eplerenone in the rat heart: interaction with locally synthesized or blood-derived aldosterone?Wenxia Chai
Department of Pharmacology, Erasmus MC, Rotterdam, The Netherlands
Hypertension 47:665-70. 2006..The rapid, mineralocorticoid receptor-independent kinetics of aldosterone suggest that its accumulation in the heart involves cell surface binding rather than internalization...
Genomic and nongenomic effects of aldosterone in the rat heart: why is spironolactone cardioprotective?Wenxia Chai
Department of Pharmacology, Room EE1418b, Erasmus MC, Dr Molewaterplein 50, 3015 GE, Rotterdam, The Netherlands
Br J Pharmacol 145:664-71. 2005..MR blockade reduces infarct size and increases LVP recovery following coronary artery occlusion. The MR-related phenomena may underlie, at least in part, the beneficial actions of spironolactone in heart failure...
77th Scientific Sessions of the American Heart AssociationA H Jan Danser
Erasmus MC, Department of Pharmacology, Room EE1418b, Dr Molewaterplein 50, 3015GE Rotterdam, The Netherlands
Expert Opin Investig Drugs 14:203-7. 2005..The sessions were divided into basic, clinical and population science. The abstracts have been published in a supplement to Circulation (2004) 110(7)...
Is angiotensin II made inside or outside of the cell?Wenxia Chai
Department of Pharmacology, Room EE1418b, Erasmus MC, Dr Molewaterplein 50, 3015 GE Rotterdam, The Netherlands
Curr Hypertens Rep 7:124-7. 2005..It is eventually concluded that angiotensin generation at tissue sites occurs extracellularly, most likely on the cell surface...
Bradykinin, angiotensin-(1-7), and ACE inhibitors: how do they interact?Beril Tom
Department of Pharmacology, Room EE1418b, Erasmus Medical Centre, Dr Molewaterplein 50, 3015 GE Rotterdam, The Netherlands
Int J Biochem Cell Biol 35:792-801. 2003..The levels of angiotensin-(1-7) are increased during ACE inhibition, and most studies suggest that its hypotensive effects are mediated in a bradykinin-dependent manner...
ACE-versus chymase-dependent angiotensin II generation in human coronary arteries: a matter of efficiency?Beril Tom
Department of Pharmacology, Thoracic Surgery and Heart Valve Bank, Erasmus MC, Rotterdam, The Netherlands
Arterioscler Thromb Vasc Biol 23:251-6. 2003..The objective of this study was to investigate ACE- and chymase-dependent angiotensin I-to-II conversion in human coronary arteries (HCAs)...
Why are mineralocorticoid receptor antagonists cardioprotective?Wenxia Chai
Department of Pharmacology, Room EE1418b, Erasmus MC, Dr Molewaterplein 50, 3015 GE, Rotterdam, The Netherlands
Naunyn Schmiedebergs Arch Pharmacol 374:153-62. 2006..Some of these effects occur via or in synergy with angiotensin II, and involve a non-MR-mediated mechanism. This raises the possibility that aldosterone synthase inhibitors might exert beneficial effects on top of MR blockade...
